Mingyu Biotechnology

Drug Medical Device Policy / Regulatory

10th National VBP Round Results Announced: Contracts Worth Over RMB1.3 Billion

Fineline Cube Dec 31, 2024

The national Volume-Based Procurement (VBP) authorities have released comprehensive details regarding the 10th VBP round,...

Policy / Regulatory

China State Council Mandates Long-Term Care Insurance System – 0.3% Contribution Rate Targets Severe Disability Coverage Within Three Years

Company

Simcere Pharma 2025 Revenue RMB 7.7B – Innovative Drugs Drive 28% Growth, Profit Surges 86%

Company Deals

GSK Partners with SPH Keyuan Trade to Relaunch Engerix B – Hepatitis B Vaccine Targets China’s Adult Self-Paid Market

Company Drug

Lee’s Pharma Wins NMPA Approval for Intrarosa – Estrogen-Free DHEA Pessary Targets Postmenopausal Vulvovaginal Atrophy